EP Patent

EP0901786A2 — Solid pharmaceutical dispersions with enhanced bioavailability

Assigned to Bend Research Inc · Expires 1999-03-17 · 27y expired

What this patent protects

Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or biavailability in a use environment.

USPTO Abstract

Spray dried solid dispersions comprising a sparingly soluble drug and hydroxypropylmethylcellulose acetate succinate (HPMCAS) provide increased aqueous solubility and/or biavailability in a use environment.

Drugs covered by this patent

Patent Metadata

Patent number: EP0901786A2
Jurisdiction: EP
Classification: —
Expires: 1999-03-17
Drug substance claim: No
Drug product claim: No
Assignee: Bend Research Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.